Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.

Mehta SN, Goldfine AB, Abrahamson MJ, DiVincenzo R, Laffel LM.

J Diabetes Sci Technol. 2013 Jan 1;7(1):119-22.

2.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

4.

Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.

Neeser K, L├╝bben G, Siebert U, Schramm W.

Pharmacoeconomics. 2004;22(5):321-41. Review.

PMID:
15061682
5.

Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation.

Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J.

Health Technol Assess. 2004 Apr;8(13):iii, ix-x, 1-91. Review.

Supplemental Content

Write to the Help Desk